Serina Therapeutics Inc. (SER)
NYSE · Healthcare
Serina Therapeutics Inc. Total Liabilities 2017–2025
Serina Therapeutics Inc. annual total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Serina Therapeutics Inc. total liabilities as of December 31, 2025: 7.0M, a 12.42% increase year-over-year.
- Serina Therapeutics Inc. total liabilities for 2025 were 7.0M, a 12.42% increase from 2024.
- Serina Therapeutics Inc. total liabilities for 2024 were 6.2M, a 27.95% increase from 2023.
- Serina Therapeutics Inc. total liabilities for 2023 were 4.9M, a 76.37% decrease from 2022.
- Serina Therapeutics Inc. total liabilities for 2022 were 20.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Serina Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $6 |
| 2023 | $5 |
| 2022 | $21 |
| 2021 | $15 |
| 2020 | $9 |
| 2019 | $5 |
| 2018 | $2 |
| 2017 | $1 |
Serina Therapeutics Inc. Total Liabilities — FAQ
Serina Therapeutics Inc. (SER) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SER's total liabilities history?
The chart and table above show Serina Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.